Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Allergen immunotherapy (9)
  • Asthma (18)
  • Basic immunology (4)
  • x Biologicals (11)
  • Biomarkers (5)
  • Dermatology (3)
  • Drug allergy (1)
  • ENT (2)
  • Eosinophilic esophagitis (1)
  • Epidemiology (2)
  • Genomics and proteomics (1)
  • Infections (1)
  • Ocular allergy (2)
  • One Health (1)
  • Pediatrics (2)
Poster available until
Poster categories
  • Thematic Poster Session (11)
keywords
Session Reference
  • x L-TPS02 (9)
  • L-TPS07 (11)
  • L-TPS08 (1)
  • L-TPS09 (3)
  • L-TPS10 (1)
  • L-TPS19 (1)
  • L-TPS21 (1)
  • TPS06 (8)
  • x TPS09 (2)
  • TPS17 (4)
  • TPS18 (9)
  • TPS29 (1)
  • TPS51 (1)
  • TPS52 (5)
  • TPS55 (10)
  • TPS56 (5)
  • TPS57 (1)
  • TPS63 (1)
  • TPS67 (9)
  • TPS69 (2)
11 results
Thumbnail

D1.116 - Severe Airflow Limitation Unmasked by NSAID Hypersensitivity: A Case of Undiagnosed Persistent Asthma with Nasal Polyposis

Thumbnail

D1.117 - Combing dual biologics therapy for severe asthma : a series of ten cases

Thumbnail

D1.118 - The Use of Long-Acting Muscarinic Antagonist in the Treatment of Asthma: A Latin-American 2 Specialized Asthma Center Experience

Thumbnail

D1.119 - Anti-Inflammatory Effects of miRNA-Mediated Extracellular Vesicles Derived from Mesenchymal Stem Cells in a Murine Asthma Model

Thumbnail

D1.123 - Inhibition of the Interleukin Cytokines using novel Peptide Inhibitors for Allergy and Asthma Treatment

Thumbnail

D1.124 - Predictive Factors of Clinical Remission in Severe Eosinophilic Asthma Treated with Benralizumab

Thumbnail

D1.125 - Biological therapy in severe asthma: 20 years of experience at the Hospital Universitario de Burgos

Thumbnail

D1.129 - Bispecific Antibody Targeting IL-33 and TSLP for Treating Asthma and COPD

Thumbnail

D1.131 - TRough levels In plasma of dUpilumab and Mepolizumab in Patients with severe astHma (TRIUMPH)

Thumbnail

D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Thumbnail

D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM